Combination antiangiogenic therapy in advanced breast cancer: a phase 1 trial of vandetanib, a VEGFR inhibitor, and metronomic chemotherapy, with correlative platelet proteomics

Overview of attention for article published in Breast Cancer Research and Treatment, September 2012

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 39 Dimensions

Readers on

mendeley: 45 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 363 followers.

[VEGF] Combination antiangiogenic therapy in advanced breast cancer: a phase 1 trial of vandetanib, a VEGFR i... http://t.co/NIfo7fPH PM

Reply Repost Favourite